New Key Statistics Module, Z-Score and F-Score
MIL:FDA Key Ratios
Market Cap € M | 21.52 |
Enterprise Value € M | 22.54 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.43 |
Price/Sales | 0.16 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) € M | 28.00 |
EPS (TTM) € | -0.19 |
Beneish M-Score | -2.34 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -94.00 |
EV-to-EBIT | -28.11 |
EV-to-EBITDA | 46.87 |
PEG | -- |
Shares Outstanding M | 31.09 |
Net Margin (%) | -4.57 |
Operating Margin % | -5.76 |
Pre-tax Margin (%) | -4.28 |
Quick Ratio | 0.13 |
Current Ratio | 0.86 |
ROA % (ttm) | -3.70 |
ROE % (ttm) | -33.71 |
ROIC % (ttm) | -8.40 |
Dividend Yield % | -- |
Altman Z-Score | 0.83 |
MIL:FDA Number of Guru Trades
MIL:FDA Volume of Guru Trades
Gurus Latest Trades with MIL:FDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
MIL:FDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data